Ledyard National Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ledyard National Bank’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-225	Closed	-$16K	–	642
2018 Q4	$16K	Hold	225	–	–	﹤0.01%	557
2018 Q3	$22K	Sell	225 -225	-50%	-$21.8K	﹤0.01%	513
2018 Q2	$43K	Hold	450	–	–	0.01%	445
2018 Q1	$39K	Hold	450	–	–	﹤0.01%	466
2017 Q4	$38K	Hold	450	–	–	﹤0.01%	484
2017 Q3	$39K	Hold	450	–	–	0.01%	476
2017 Q2	$35K	Hold	450	–	–	0.01%	448
2017 Q1	$31K	Hold	450	–	–	﹤0.01%	464
2016 Q4	$27K	Hold	450	–	–	﹤0.01%	366
2016 Q3	$30K	Hold	450	–	–	0.01%	362
2016 Q2	$24K	Sell	450 -1,775	-80%	-$97.3K	﹤0.01%	371
2016 Q1	$115K	Sell	2,225 -570	-20%	-$29.6K	0.02%	235
2015 Q4	$197K	Buy	2,795 +2,345	+521%	+$160K	0.04%	183
2015 Q3	$28K	Hold	450	–	–	0.01%	367
2015 Q2	$38K	Hold	450	–	–	0.01%	334
2015 Q1	$34K	Hold	450	–	–	0.01%	338
2014 Q4	$28K	Hold	450	–	–	0.01%	367
2014 Q3	$23K	Hold	450	–	–	﹤0.01%	353
2014 Q2	$23K	Hold	450	–	–	﹤0.01%	362
2014 Q1	$21K	Sell	450 -1,350	-75%	-$69.1K	﹤0.01%	362
2013 Q4	$79K	Hold	1,800	–	–	0.01%	217
2013 Q3	$77K	Hold	1,800	–	–	0.01%	202
2013 Q2	$63K	Buy	+1,800	New	+$63.3K	0.01%	208

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ledyard National Bank's XBI Position: Q1 2019 in Review

Ledyard National Bank sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2019, closing a stake of 225 shares — an estimated $16K sold.

Ledyard National Bank first reported a position in XBI in Q2 2013 and held it in 23 quarters. The position peaked at $197K in Q4 2015. 451 funds tracked by Wall St. Rank hold XBI as of Q1 2019.

Ledyard National Bank reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2019 after selling out during the quarter.
Ledyard National Bank sold 225 State Street SPDR S&P Biotech ETF shares in Q1 2019, an estimated $16K.
Ledyard National Bank first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 23 quarters.
Ledyard National Bank's State Street SPDR S&P Biotech ETF position peaked at $197K in Q4 2015.
451 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2019.

Based on Ledyard National Bank's 13F filing for Q1 2019, filed 12 Apr 2019.